Navigation Links
The 3 percent solution: Unpopular drug companies still push discovery

Madison, Wis. - John McNeish gives it a light-hearted spin when he talks about drug companies being one of the least trusted institutions in America.

"The polls say only 3 percent of the people in the country have a favorable view of drug companies," Pfizer executive McNeish told a group of about 75 people, mostly scientists, who gathered at Universit......

Full article >>> al for drug discovery," McNeish said.

While Pfizer has worked with mouse stem cells, it has not conducted experiments involving human stem cells. While McNeish and his colleagues see tremendous potential in working with such cells, they also see many financial and public policy risks.

The costs of bringing a drug to market are enormous, not counting the ads. Pfizer may unveil a c......

Full article >>> ncil and the Wisconsin Innovation Network. He is the former associate editor of the Wisconsin State Journal in Madison.

The opinions expressed herein or statements made in the above column are solely those of the author, and do not necessarily reflect the views of Wisconsin Technology Network, LLC. (WTN). WTN, LLC accepts no legal liability or responsibility for any claims made or op......

Full article >>>
'"/>

Source:wistechnology.com By Tom Still 09/12/05


Related biology technology :

1. National angel investment grew 11 percent in `06
2. Musicnotes reports 45 percent growth in 2006
3. Fiserv posts 30 percent quarterly loss
4. RedPrairie exec calls for 50 percent tax cut
5. Renaissance earnings down 46 percent
6. GE Healthcare third-quarter profits up 17 percent
7. Criticare reports 20.3 percent increase in sales
8. Rockwell Automation ups quarterly dividend by 36 percent
9. Its 99 percent certain: Research cannot rely on adult stem cells alone
10. A disgusting video: U.S. companies sell out Americans
11. Pre-eminent, web-based companies owe success to corporate venturing
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/10/2017)... ... October 10, 2017 , ... The ... prestigious awards honoring scientists who have made outstanding contributions to analytical ... during Pittcon 2018, the world’s leading conference and exposition for laboratory science, which ...
(Date:10/9/2017)... ... October 09, 2017 , ... At its national board meeting in North ... in Harvard University’s Departments of Physics and Astronomy, has been selected for membership in ... winning team for the 2015 Breakthrough Prize in Fundamental physics for the discovery of ...
Breaking Biology Technology:
(Date:4/13/2017)... 2017 UBM,s Advanced Design and Manufacturing event ... emerging and evolving technology through its 3D Printing and ... alongside the expo portion of the event and feature ... focused on trending topics within 3D printing and smart ... event will take place June 13-15, 2017 at the Jacob ...
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
(Date:4/5/2017)... , April 5, 2017 Today ... announcing that the server component of the HYPR platform ... for providing the end-to-end security architecture that empowers biometric ... HYPR has already secured over 15 million users ... including manufacturers of connected home product suites and physical ...
Breaking Biology News(10 mins):